NCT02527343 - The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 28, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

November 13, 2019

Conditions

Familial Partial Lipodystrophy

Interventions

DRUG

volanesorsen

300 mg of volanesorsen administered subcutaneous (SC) injection, once-weekly (QW).

DRUG

Placebo

Volanesorsen-matching placebo administered SC injection.

Trial Locations (12)

IONIS Investigative Site, Leuven

IONIS Investigative Site, Philadelphia

IONIS Investigative Site, Morehead City

IONIS Investigative Site, Ann Arbor

IONIS Investigative Site, Münster

IONIS Investigative Site, Rochester

IONIS Investigative Site, St Louis

IONIS Investigative Site, Dallas

IONIS Investigative Site, Moscow

IONIS Investigative Site, Rio de Janeiro

IONIS Investigative Site, Halifax

IONIS Investigative Site, Amsterdam-Zuidoost